CIHR Innovation and Industry Programs
In partnership with
sanofi-aventis
Important Dates | |||||||||||||||||||||||||||||||||||||||||
Opportunity Launched | June 2006 | ||||||||||||||||||||||||||||||||||||||||
Content Last Updated | (No updates since launch) | ||||||||||||||||||||||||||||||||||||||||
January 16, 2007 | Registrations must be courier stamped by this date. | ||||||||||||||||||||||||||||||||||||||||
March 1, 2007 | Full applications must be courier stamped by this date. | ||||||||||||||||||||||||||||||||||||||||
July 30, 2007 | Anticipated notification of decision. | ||||||||||||||||||||||||||||||||||||||||
Funds Available | |||||||||||||||||||||||||||||||||||||||||
CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them.
A quota of seven awards are available. If however no qualified candidates are identified as indicated by the allotment for that country and/or region, the remaining funds will be carried forward to future years. Funding for up to seven awards are offered through this partnership in this round of the Program. Scholars will receive funding in Canadian dollars based on the following table
The stipend level is related to the major degree, licensure (where applicable) and experience of the applicant. Stipends are valued in Canadian dollars and are taxable. This award is non-renewable. | |||||||||||||||||||||||||||||||||||||||||
Summary | |||||||||||||||||||||||||||||||||||||||||
The primary goal of the CANADA-HOPE Scholarship Program is to further develop international collaborative efforts between researchers. The short term goal is to enable promising individuals to be mentored by prominent Canadian researchers. The long term objective of the Program is to enable promising scientists and clinicians from Low and Middle Income Countries (LMIC), as identified by the Canadian International Development Agency (CIDA) and the United Nations (UN), to be exposed to some of the best science, laboratories and training environments in Canada . This objective will be realized by developing research training opportunities which in the long term, would lead to the development of sustainable programs to help people in developing countries. The first three rounds of this program will focus on sub-continental South Asia . It is the intent to gradually expand the Program to other regions of the world. |
Background
Partners
Objectives
Eligibility
Allowable Costs
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
Communications Requirements
Monitoring, Performance Measurement and Evaluation
How to Apply
Contact Information
Description of Partners
Appendix
The CANADA-HOPE Scholarship Program, founded in 2004, is dedicated to improving the health of people in developing countries. This Program was made possible by a grant from sanofi-aventis, as a consequence of the successful HOPE clinical trial led by Dr. Salim Yusuf and other Canadian investigators. This donation of approximately $1.7 Million was matched by CIHR to create the CANADA-HOPE Scholarship Program.
The CIHR Innovation and Industry Programs Branch is dedicated to identifying and developing collaborations with other CIHR institute(s), branch(es) or office(s), funding organizations and stakeholders to enhance the availability of funding for this strategic initiative, and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of this particular initiative. Applicants are invited to visit the Descriptions of Partners to find a list of partners and their respective mandates and/or strategic interests. This list will continue to evolve as new partners join in this initiative. The specific research foci and requirements for each partner are outlined in the section "Objectives."
The goals of the Program are to encourage a broad spectrum of foreign post-doctoral scholars (PhDs, MDs or health professionals) to train in health and health related areas which affect people in LMIC.
Relevant Research Areas
Eligible research areas include clinical epidemiology, population health, clinical trials, the health sciences, global health and areas which can have an impact on the health of people in LMIC. The scholars must:
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Randomized Controlled Trials (RCTs) will not be considered under this RFA.
Trainee Stipends
The annual stipend level for those with a PhD degree (or equivalent) is $40,000 per annum.
The following stipend levels apply to health professionals who hold licensure in Canada or hold an educational license at the time of taking up the award. The stipend level is dependent upon the number of years of research or clinical training completed since obtaining the health professional degree.
Specific Eligibility Requirements
In order to be eligible for this award, the scholar must have a mentor in a related field at an eligible Canadian institution and the sponsorship of an eligible institution in sub-continental South Asia (India, Pakistan, Bangladesh Sri Lanka and Nepal). The scholarships are intended for men and women of high intellectual promise who may be expected to make a significant contribution to their own countries following their return from study in Canada . Anyone who has obtained Canadian citizenship or who has applied for permanent residency in Canada shall not be eligible for the award. The mentor, scholar and sponsoring institution(s) must meet the following requirements:
a) Mentor
b) Scholar
c) Sponsoring Institution(s)
The faculty members must be actively involved in clinical medicine, health related research, global health and/or population health research and demonstrate the potential to develop functional linkages to collaborative projects at other institutions. The sponsoring institutions must have adequate infrastructure, physical space, research training environment and computer facilities for its' trainees. The institutions are also required to meet the following specific criteria:
Eligibility criteria for all CIHR research personnel programs apply. Please refer to General Guidelines for Training Programs on the CIHR website.
The awards consist of a stipend and a research allowance. For the research allowance, applicants should review the Tri-Agency (CIHR , NSERC and SSHRC) financial administration guidelines Use of Grant Funds for a complete listing and description of allowable costs and activities.
A CIHR peer review committee will evaluate the full applications. Committee members are selected based on suggestions from many sources including the institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review. Peer review will be conducted in accordance with the CIHR Peer Review Process: Policies and Responsibilities of Grants Committee Members, including the standard evaluation criteria described under "Factors for Assessment" (section 6.2). CIHR recognizes that applications will emphasize different approaches to research and to knowledge translation, therefore reviewers and committees are expected to weight criteria such as these differently from one application to another.
CIHR Peer review
The research training and potential for a promising career in research, in a health related area which will help people in an LMIC and the potential to develop linkages are the principal criteria, on which applications will be judged. More specifically, the points considered in the evaluation of an application are as follows:
This Request for Applications will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document. In addition to CIHR standard guidelines and requirements, the following shall apply:
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada . Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this Request for Applications and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
Award recipients are required to acknowledge CIHR, its institutes and partners in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements. The contributing institutes/partners will be identified on the Authorization for Funding and decision letter.
CIHR is committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
The application process is comprised of two steps: 1) Registration and 2) Full Application.
In the first step of the application process the Mentor or Scholar is required to submit a Registration.
The Registration:
To generate these printed pages, you must complete the following four sections of the Research Module Web form:
Applicants are advised to follow the instructions on the Acceptable Application Module Formats page, which outlines formatting requirements for attachments.
Note to applicants: CIHR is sensitive to the technical difficulties that applicants from outside of Canada may experience when using the CIHR online forms. If you have technical difficulties contact the CIHR Help Desk toll free at 1-888-603-4178 (select option 2) or 613-941-0068, or by e-mail at webforms@cihr-irsc.gc.ca.
Send the Registration by Courier to
Submit one original of the Registration to the address below, by the deadline date indicated at the beginning of this Request for Applications. Registrations completed by the scholar will be accepted by facsimile.
RE: "CANADA-HOPE Scholarship Program"
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
Fax: (613) 954-1800 (Scholar's only)
A request for the CANADA-HOPE Scholarship Program must be submitted to CIHR using the appropriate forms.
The full application must contain:
Note to applicants: CIHR is sensitive to the technical difficulties that applicants from outside of Canada may experience when using the CIHR online forms. If you have technical difficulties contact the CIHR Help Desk toll free at 1-888-603-4178 (select option 2) or 613-941-0068, or by e-mail at mailto:mwebforms@cihr-irsc.gc.ca.
Send the completed application by Courier to:
Submit one original and one copy of the full application to the address below, by the deadline date indicated at the beginning of this Request for Applications.
RE: "CANADA-HOPE Scholarship Program"
Innovations and Industry Programs Branch
Canadian Institutes of Health Research
Room 97, 160 Elgin Street
Address locator: 4809A
Ottawa, Ontario K1A 0W9
For questions on CIHR funding guidelines, how to apply, and the peer review process contact:
Prabha Singh
Program Delivery Officer
Canadian Institutes of Health Research
Telephone: (613) 952-0823
Fax: (613) 954-1800
Email: canada-hope@cihr-irsc.gc.ca
Canadian Institutes of Health Research (CIHR)
CIHR is Canada's major federal funding agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
sanofi-aventis
sanofi-aventis, with global headquarters in Paris, France, is one of the leading pharmaceutical companies in Canada . We are dedicated to protecting health and combating disease by working to make innovative, effective and safe medicines available to physicians and patients throughout the world. To accomplish our goal, we rely on our strong research focus and place the patient at the heart of our efforts. For more information on sanofi-aventis, visit the sanofi-aventis our web site.